Zambon Co SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The analyst’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Zambon Co SpA (Zambon) manufactures pharmaceutical and fine chemical products. The company offers pharmaceutical products for the central nervous system, respiratory, pain management, women’s healthcare, and rare diseases and specialties, including Parkinson’s disease and cystic fibrosis. It also provides active pharmaceutical ingredients (API), intermediates and custom synthesis services. The company has manufacturing plants in Cadempino, Switzerland; Haikou, China; Vicenza, Italy; and Barueri, Brazil. It distributes products directly and also through a network of distributors across North America, Latin America, Europe, the Middle East, and Africa, and Asia. Zambon is headquartered in Milano, Italy.Zambon Co SpA Key Recent Developments
- May 02, 2024: Giovanni Magnaghi is the New Chief Executive Officer of Zambon
- Feb 28, 2024: Zcube Launches the 2024 Edition of Open Accelerator, an International Acceleration Program Aimed at Life Sciences Startups with Focus on Women's Health and Femtech
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Company’s Recent Developments
Section 5 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Valpharma International SpA
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Serelyspharma SAM
- FB Health SpA
- Recordati SpA
- Cambrex Corp
- Sandoz SpA
- Chiesi Farmaceutici SpA